Previous close | 28.90 |
Open | 26.50 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 190.00 |
Expiry date | 2024-07-19 |
Day's range | 26.50 - 28.90 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.